rFVIII-Fc (Produced by AryoGen Pharmed Co.) Pharmacokinetic Study

计划入组 50 人 · 首次发布于 2023 年 11 月 18 日

A Phase 3 Study to Evaluate the Efficacy of JY09 Compared With Placebo in T2DM Patients

计划入组 270 人 · 首次发布于 2024 年 2 月 12 日

Clinical Study of Recombinant Humanized CTLA-4-FC Fusion Protein Injection in Healthy Subjects

计划入组 46 人 · 首次发布于 2022 年 2 月 25 日

S1-Fc fusion protein

rhEPO-Fc Fusion Protein

ApoM-Fc engineered fusion protein

FUSION PHARMACEUTICALS

Nepal

Biomea Fusion

United States

FC-Gen Acquisition, Inc.

United States

Fc Fusion Therapeutics Market Poised to Reach $53.5 Billion by 2035 as Oncology Pipeline Expands

Akston Launches First-in-Class Canine Cancer Immunotherapy Trial Using Novel Fc-Fusion Platform

FDA Clears HanchorBio's HCB101 Single-Patient Expanded Access Protocol, a First for SIRPα-Fc Fusion Proteins